Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Syncona Portfolio Limited investment portfolio
Syncona Portfolio Limited has made numerous investments in companies such as Resolution Therapeutics, Biomodal, and Quell Therapeutics within the Biotech sector.
unknown
Portfolio
14
Team
0
Portfolio (14)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
| Beacon Therapeutics Limited Beacon Therapeutics is a clinical‑stage biotechnology company developing gene‑therapy treatments for blinding retinal diseases, including X‑linked retinitis pigmentosa, geographic atrophy and cone‑rod dystrophy. Its products target patients with both rare and more common ocular conditions. | Healthcare & Life Sciences | London | Confirmed | 2025-10-14 |
Shareholding changes (15)
Syncona Portfolio Limited's positions across portfolio companies2026
- SERIES B1 7,472,342 → 10,805,675
2025
- SERIES B2 PREFERRED 4,156,868 → 10,676,987
Articles (1)
- Mosaic Therapeutics Secures £261.4k Growth Funding Amidst Evolving UK Biotech Landscape24 Apr 2026Mosaic Therapeutics